| 标题 |
Orelabrutinib with anti-CD20 monoclonal antibodies is highly effective and well-tolerated as first-line therapy for marginal zone lymphoma |
| 网址 | |
| DOI |
10.1097/bs9.0000000000000286
doi
|
| 其它 |
期刊:Blood Science 作者:Na Yao; Cheng-Ji Wang; J. Cong; Xin Li; Lei Yang; et al 出版日期:2026-04-13 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)